Banque Cantonale Vaudoise Editas Medicine, Inc. Transaction History

Banque Cantonale Vaudoise

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$9.99 - $21.35 $1,998 - $4,270	200 Added 11.59%	1,925 $23,000
Q3 2021 Oct 29, 2021	BUY	$39.27 - $72.94 $8,835 - $16,411	225 Added 15.0%	1,725 $71,000
Q2 2021 Aug 11, 2021	BUY	$31.29 - $56.64 $15,645 - $28,320	500 Added 50.0%	1,500 $69,000
Q3 2020 Oct 30, 2020	BUY	$28.06 - $37.16 $28,060 - $37,160	1,000 New	1,000 $28,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.